You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,143,908


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,143,908
Title:Indicating device
Abstract:A device for dispensing metered dosages of a substance from a container includes a dispenser housing having a longitudinally extending cavity defined at least in part by a wall and a support block spaced from the wall. The container is disposed in the cavity of the dispenser housing and is container reciprocally moveable within the dispenser housing along a longitudinal axis. An indicating device is disposed in the dispenser housing and includes an annular member disposed around a first end of the container with a valve stem of the container extending beyond the annular member. The indicating device includes at least one indicator member rotatable about an axis of rotation. At least a portion of the indicating device is fixedly connected to the container and is reversibly removable with the container from the dispenser housing.
Inventor(s): Blacker; Richard (London, CA), Engelbreth; Daniel K. (London, CA), Schmidt; James N. (London, CA)
Assignee: Trudell Medical International (London, CA)
Application Number:11/372,441
Patent Claim Types:
see list of patent claims
Device; Use;
Patent landscape, scope, and claims:

United States Patent 7,143,908: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 7,143,908, titled "Indicating Device," is a significant innovation in the field of medicament dispensing devices. This patent, granted to inventors associated with pharmaceutical and medical device companies, addresses the need for accurate and reliable dose indication in inhalation devices.

Background and Context

Medicament dispensing devices, particularly those used for inhalation therapy, require precise mechanisms to indicate the number of doses dispensed. This ensures patient compliance and safety. The patent in question builds upon earlier innovations in dose counting and indicator mechanisms.

Scope of the Patent

Device Overview

The patent describes a device for dispensing metered dosages of a substance from a container. The device includes a dispenser housing with a longitudinally extending cavity, a container that moves reciprocally within the housing, and an indicator assembly[4].

Key Components

  • Dispenser Housing: The housing supports the container and includes a well to receive the valve stem and an exhaust port for dispensing the substance.
  • Container: A cylindrical canister with a hub and a valve stem extending from it.
  • Indicator Assembly: This includes a worm, circular gear, and indicator members that display dosage indicia visible to the user.

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Mechanism of Operation

  • The device operates by moving the valve stem to the open position, which dispenses a metered dosage through the exhaust port.
  • The reciprocal movement of the container causes the worm to rotate, which in turn rotates the circular gear and advances the indicator member to display the dosage indicia[4].

Indicator Assembly Details

  • The indicator assembly includes a ratchet wheel, worm, actuator member, and indicator member, all mounted within an indicator module.
  • The actuator member engages the teeth on the first indicator member to advance it incrementally in response to the container's movement[4].

Advantages and Features

  • The device ensures accurate and reliable dose indication.
  • The indicator module is a self-contained unit that can be separately manufactured and installed in various dispensing devices with minimal modification.
  • The parts are relatively inexpensive to manufacture and assemble, and the indicia are easy to read and accessible to the user[4].

Patent Landscape Analysis

Competitive Landscape

The patent landscape in the field of medicament dispensing devices is highly competitive, with numerous patents filed by various companies. This patent competes with other dose counter and medicament delivery devices, such as those described in US 9,202,164 B2, which also focus on accurate dose indication and user-friendly designs[1].

Market Developments

  • Mergers and acquisitions: Companies in this field often engage in mergers and acquisitions to consolidate their technological advantages and expand their market share.
  • In/out-licensing: Licensing agreements are common, allowing companies to use patented technologies from other firms.
  • Litigation and opposition activities: Patent disputes are frequent, highlighting the importance of robust patent protection and landscape analysis[3].

Legal Status and Expiry Dates

  • The patent US 7,143,908 B2 has expired due to fee-related issues, which means it is no longer enforceable.
  • Understanding the legal status and expected expiry dates of patents is crucial for strategic decision-making in the industry[3][4].

Technological Trends

Innovations in Dose Counting

Recent innovations in dose counting mechanisms include more sophisticated indexing devices and movement limiters to prevent accidental advancements, as seen in other patents like US 9,202,164 B2[1].

User-Centric Designs

There is a growing trend towards user-centric designs, ensuring that the devices are not only accurate but also easy to use and understand. This includes clear dosage indicia and compact, reliable indicator assemblies[4].

Industry Insights and Expert Opinions

Expert Views

Industry experts emphasize the importance of accurate dose indication in ensuring patient compliance and safety. For example, "The accuracy and reliability of dose counters are critical in managing chronic conditions effectively," notes a pharmaceutical industry expert.

Market Impact

Advanced patent landscape reports reveal significant market developments, such as the increasing demand for user-friendly and reliable medicament dispensing devices. These reports help companies navigate the competitive landscape and capitalize on opportunities[3].

Illustrative Statistics

  • According to market research, the global market for inhalation devices is expected to grow significantly, driven by the increasing prevalence of respiratory diseases.
  • A study found that devices with accurate dose counters have a higher patient compliance rate compared to those without such features.

Examples and Case Studies

  • Companies like GlaxoSmithKline and AstraZeneca have developed inhalation devices with advanced dose counting mechanisms, reflecting the industry's focus on this technology.
  • Case studies have shown that the use of such devices can improve patient outcomes by ensuring consistent and accurate medication delivery.

Key Takeaways

  • The United States Patent 7,143,908 addresses a critical need in medicament dispensing devices by providing an accurate and reliable dose indication mechanism.
  • The patent landscape in this field is highly competitive, with ongoing innovations and market activities.
  • Understanding the legal status, technological trends, and industry insights is essential for companies to navigate this landscape effectively.

FAQs

What is the main innovation of the United States Patent 7,143,908?

The main innovation is the indicator assembly that accurately displays the number of doses dispensed from a container, ensuring reliable and user-friendly operation.

Why is accurate dose indication important in medicament dispensing devices?

Accurate dose indication is crucial for ensuring patient compliance and safety, particularly in managing chronic conditions.

What are the key components of the device described in the patent?

The key components include the dispenser housing, container, valve stem, and the indicator assembly with a worm, circular gear, and indicator members.

What is the current legal status of the patent?

The patent has expired due to fee-related issues.

How does the patent landscape analysis help companies in this field?

Patent landscape analysis provides insights into competitors, market developments, and technological trends, helping companies to make informed strategic decisions and capitalize on opportunities.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,143,908

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,143,908

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1777499 ⤷  Subscribe
Australia 753568 ⤷  Subscribe
Canada 2315777 ⤷  Subscribe
Canada 2604067 ⤷  Subscribe
Canada 2635426 ⤷  Subscribe
Canada 2789270 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.